We hypothesize that a general mechanism by which the diseases and drugs identified in our study may trigger the clinical presentation of type 1 diabetes is that these conditions can change the state of metabolism and thereby increase insulin requirement in the body. The gene discussed is INS; the disease is type 1 diabetes mellitus.